Current Research Studies

Cancer – AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL)

Condition or Therapy:

Acute Lymphoblastic Leukemia


Cancer and Blood Disorders
Study Number: AALL00932

What is the goal of this study?

Researchers want to determine how to improve disease free survival in patients with standard risk B-Acute Lymphoblastic Leukemia (ALL).

Who can join the study?

This study may be a good fit for children and young adults who:

  • Are 1 to 30 years old, and
  • Are newly diagnosed with standard risk B-Acute Lymphoblastic Leukemia (ALL).

What will happen if my child takes part in this study?

You can read more about this study on

Who can I contact for more information?

To learn more, call 206-987-2106 or email the study coordinator.

Study Location(s):

Seattle Children's Main Hospital Campus

Principal Investigator:

Dr. Douglas Hawkins